abbvie glp-1 receptor agonist medications Evolution of GLP‐1 Agonists for Diabetes Treatment List of GLP-1 Receptor Agonists
Description
This long-acting profile makes them a promising therapy for people with Type 2 diabetes, which was their original intent

The effects of GLP-1RAs on thyroid cancer risk Multiple retrospective observational studies and spontaneous case reports suggest a possible association between GLP-1RAs and an elevated risk of thyroid cancer [20, 21]

Some are the same drug in different doses

Medicines under this GLP-1 receptor agonist category, they not only improve diabetes, Majure said, but they also lead to people not dying as frequently because of heart attacks and strokes. Among gastroenterologists, 72 percent had prescribed GLP-1RAs to treat nonalcoholic fatty liver disease (NAFLD)

GLP-1 Secretion While GLP-1 secretion was originally described in response to glucose, it also occurs with ingestion of a mixed meal and the GLP-1 response is greater than to glucose alone indicating synergy in the stimulation by fat and protein along with glucose (1, 78, 132)

www.abbvie.com/science/pipeline.html 62
